Using the IndicationIQ workspace

These terms govern your use of the IndicationIQ workspace at indicationiq.app and related services (the “Service”). By creating an account or using the Service, you agree to these terms (version 2026-08-03).

If you use the Service on behalf of an organisation, you confirm you have authority to bind that organisation. The organisation is responsible for its users' compliance.

IndicationIQ helps pharmaceutical insight teams and agencies collect, review, and export evidence from publicly posted social media and open forum content, scoped to a configured medical indication.

Outputs are research inputs — named unmet needs, language patterns, HCP themes, and supporting verbatim quotes — not medical, regulatory, or legal advice.

Access to the Service is licensed per Indication — one configured therapy-area project, covering the markets and data sources set out in your order form. The Service is licensed on a subscription basis and is not sold as one-off reports.

Unless your order form states otherwise, each licence runs for a minimum term of twelve months from the start date and renews for successive twelve-month terms unless either party gives written notice at least 30 days before the end of the current term.

The number of concurrent Indications, users, and markets available to you is set by your plan and order form. Additional Indications, markets, or add-ons are licensed separately.

Fees are set out in your order form and are payable in advance, annually or quarterly as agreed. Invoices are due within 30 days of issue unless stated otherwise. All fees exclude VAT and other applicable taxes.

Fees for a minimum term are non-refundable, including where you pause an Indication or stop using the Service before the term ends. We may suspend access to the Service where an undisputed invoice remains unpaid more than 30 days after its due date, having given you written notice and a reasonable opportunity to pay.

We may change fees for a renewal term by giving at least 60 days' written notice before the end of the current term.

Each licensed Indication includes an allowance of stored posts per term, as set by your plan. Where an Indication reaches its allowance, the Service stops storing further posts for that Indication until the allowance is increased or the term renews. Collection already in progress may be truncated to stay within the allowance.

You may pause a licensed Indication and re-point the licence to a different Indication when a project concludes. Re-pointing is subject to fair use: a licence covers sequential, not concurrent projects. Where usage indicates that a single licence is being used to service projects that would ordinarily run in parallel, or where re-pointing frequency materially exceeds normal project turnover, we may require additional licences. We will raise this with you before taking any action on your account.

A paused Indication becomes read-only: collection and configuration stop, while existing evidence, findings, and reports remain available to you.

Raw posts for a paused Indication are retained for 90 days by default and are then automatically purged. Aggregate outputs — barrier names, counts, themes, and frequency statistics — are retained so previously produced reports continue to work.

You may reactivate a paused Indication at any time before its raw evidence is purged, provided your plan has a free Indication slot. After purge, an Indication cannot be reactivated and would need to be set up again. Retention periods can be shortened at any time in workspace settings, or varied by agreement.

If you are an agency or consultancy, you may use the Service to produce deliverables for the end clients named in your order form. You remain responsible for your users' compliance with these terms and for your arrangements with those end clients, including the controller-side lawful basis and transparency obligations described below.

Removing IndicationIQ branding from exports, or applying your own or a client's branding, requires the white-label rights add-on. Sharing workspace access with parties outside your organisation and named end clients requires our prior written agreement.

A licence is scoped to the Indications on your order form. It does not permit building a standing cross-client or cross-indication record of individuals — see acceptable use below.

For research processing within the Service, your client organisation (or your own organisation, if you are the end client) is typically the data controller. IndicationIQ acts as a data processor and processes personal data only under the controller's documented instructions and a signed data processing agreement.

Our privacy notice explains how we handle publicly posted content. Exporting client deliverables is additionally governed by our export terms, which you must accept before each report download.

You agree not to use the Service to:

• Contact, advertise to, or profile individuals identified in source material for marketing purposes
• Build or maintain a standing, searchable database of identifiable patients across projects or clients
• Reuse one client's project data for another client or purpose without a new lawful basis and contract
• Train machine-learning models on verbatim quotes stored in the Service
• Scrape or attempt to access closed, login-gated, or private health communities through the Service
• Violate applicable law, platform terms, or third-party rights

Accounts are personal to the named user. Logins are licensed per user and must not be shared, transferred, or used by more than one person. Where your plan sets a number of named users, additional people need additional user licences rather than shared credentials.

You are responsible for safeguarding your credentials and for all activity under your account, including activity by anyone you give access to, whether or not you authorised what they did. Anyone using the Service through your account is bound by these terms, and you remain liable for their compliance.

Sharing credentials outside your organisation is a material breach and may result in immediate suspension. Where you need to give a colleague or an end client access, invite them as a user or share an export instead.

Notify us promptly at [email protected] if you suspect unauthorised access.

IndicationIQ retains all rights in the Service, software, and branding. You retain rights in your configuration, review decisions, and exported deliverables, subject to the rights of third parties in underlying source posts.

You grant IndicationIQ a limited licence to host and process your project data solely to operate the Service under your instructions.

We aim for reliable operation but do not guarantee uninterrupted access. Public platform APIs and collection methods may change without notice, affecting coverage for a given indication.

We may update these terms. Material changes will be reflected by a new version date. Continued use after an update constitutes acceptance of the revised terms.

The Service is provided “as is” to the extent permitted by law. We do not warrant completeness of public-source coverage, absence of error in automated coding, or fitness for a particular regulatory submission.

To the extent permitted by law, IndicationIQ is not liable for indirect or consequential loss arising from use of insights or exports. Our total liability for any claim relating to the Service is limited to fees paid for the Service in the twelve months before the claim, or £100 if no fees have been paid, unless a mandatory applicable law provides otherwise.

We may suspend or terminate access for breach of these terms or for operational, legal, or security reasons. You may stop using the Service at any time. Provisions that by nature should survive (including data protection obligations, acceptable-use restrictions, and liability limits) continue after termination.

Questions about these terms: [email protected]. Privacy enquiries: [email protected].

Draft — for legal review. Engineering-prepared template; do not rely on it without counsel.